Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders
โ Scribed by Magali Reyes; Roza Olah; Krisztina Csaba; Ilse Augustyns; Marielle Eerdekens
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 288 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1018-8827
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract This subgroup analysis of the 6โmonth, openโlabel Switch to Risperidone Microspheres (StoRMi) trial evaluated longโterm safety and efficacy of a direct conversion to risperidone longโacting injectable (RLAI) in 52 elderly patients (โฅ65 years) with psychosis stabilized on oral or depot a
## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Longโacting risperidone, the first longโacting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi